GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » YoY EPS Growth

Turk Ilac ve Serumnayi (IST:TRILC) YoY EPS Growth : 77.78% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Turk Ilac ve Serumnayi's YoY EPS Growth for the quarter that ended in Sep. 2023 was 77.78%.

Turk Ilac ve Serumnayi's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was ₺0.29.


Turk Ilac ve Serumnayi YoY EPS Growth Historical Data

The historical data trend for Turk Ilac ve Serumnayi's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi YoY EPS Growth Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EPS Growth
Get a 7-Day Free Trial 74.51 -6.74 148.19 11.65 78.26

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 217.65 129.76 3.77 14.58 77.78

Turk Ilac ve Serumnayi YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Turk Ilac ve Serumnayi's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EPS Growth (A: Dec. 2022 )
=(Earnings per Share (Diluted) (A: Dec. 2022 )-Earnings per Share (Diluted) (A: Dec. 2021 ))/ | Earnings per Share (Diluted) (A: Dec. 2021 ) |
=(0.41-0.23)/ | 0.23 |
=78.26 %

Turk Ilac ve Serumnayi's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EPS Growth (Q: Sep. 2023 )
=(Earnings per Share (Diluted) (Q: Sep. 2023 )-Earnings per Share (Diluted) (Q: Sep. 2022 )) / | Earnings per Share (Diluted) (Q: Sep. 2022 )) |
=(0.288-0.162)/ | 0.162 |
=77.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines